Cytokines*
|
Exposed/no PM vs non-exposed
|
Past PM vs non-exposed
|
Chronic PM vs non-exposed
|
Acute PM vs non-exposed
|
---|
Coeff (SE)
|
P
|
Coeff (SE)
|
P
|
Coeff (SE)
|
P
|
Coeff (SE)
|
P
|
---|
TLR7/8 responses using log10 of ratio cytokines concentrations
|
Pro
|
IFN-α
|
0.15 (0.08)
|
0.079
|
0.19 (0.08)
|
0.018
|
0.09 (0.09)
|
0.359
|
0.08 (0.15)
|
0.591
|
IL-1RA
|
0.15 (0.12)
|
0.223
|
0.22 (0.11)
|
0.049
|
0.15 (0.14)
|
0.263
|
0.22 (0.22)
|
0.308
|
IL-1β
|
0.13 (0.20)
|
0.522
|
0.36 (0.18)
|
0.049
|
0.32 (0.22)
|
0.140
|
0.11 (0.35)
|
0.765
|
TNF
|
0.28 (0.24)
|
0.238
|
0.55 (0.22)
|
0.013
|
0.31 (0.26)
|
0.229
|
0.36 (0.42)
|
0.387
|
Th1
|
IL-12
|
0.18 (0.16)
|
0.259
|
0.34 (0.14)
|
0.015
|
0.30 (0.17)
|
0.074
|
0.30 (0.27)
|
0.276
|
IL-2
|
0.12 (0.07)
|
0.092
|
0.15 (0.06)
|
0.019
|
0.14 (0.08)
|
0.081
|
0.09 (0.12)
|
0.448
|
IL-2R
|
0.16 (0.10)
|
0.103
|
0.23 (0.09)
|
0.012
|
0.19 (0.11)
|
0.081
|
0.15 (0.18)
|
0.398
|
IFN-γ
|
0.18 (0.12)
|
0.137
|
0.29 (0.11)
|
0.008
|
0.25 (0.13)
|
0.056
|
− 0.03 (0.21)
|
0.898
|
Th2
|
IL-13
|
0.14 (0.13)
|
0.272
|
0.25 (0.12)
|
0.031
|
0.25 (0.14)
|
0.079
|
0.26 (0.22)
|
0.237
|
Chemokines
|
MIP-1α
|
0.47 (0.27)
|
0.085
|
0.72 (0.25)
|
0.004
|
0.59 (0.30)
|
0.049
|
0.57 (0.48)
|
0.237
|
MIP-1β
|
0.36 (0.25)
|
0.143
|
0.56 (0.22)
|
0.013
|
0.52 (0.26)
|
0.049
|
0.54 (0.43)
|
0.214
|
RANTES
|
0.17 (0.10)
|
0.097
|
0.23 (0.09)
|
0.015
|
0.21 (0.11)
|
0.062
|
0.07 (0.18)
|
0.697
|
Growth factors
|
EGF
|
0.10 (0.06)
|
0.087
|
0.12 (0.05)
|
0.017
|
0.09 (0.06)
|
0.125
|
0.09 (0.10)
|
0.360
|
FGF
|
0.16 (0.09)
|
0.069
|
0.22 (0.08)
|
0.005
|
0.23 (0.09)
|
0.017
|
0.32 (0.15)
|
0.037
|
G-CSF
|
0.18 (0.13)
|
0.170
|
0.35 (0.12)
|
0.004
|
0.29 (0.14)
|
0.047
|
0.38 (0.23)
|
0.099
|
GM-CSF
|
0.34 (0.16)
|
0.033
|
0.53 (0.14)
|
< 0.001
|
0.36 (0.17)
|
0.032
|
0.64 (0.27)
|
0.020
|
HGF
|
0.08 (0.06)
|
0.151
|
0.11 (0.05)
|
0.029
|
0.06 (0.06)
|
0.299
|
0.04 (0.10)
|
0.676
|
TLR9 responses using log10 of ratio cytokines concentrations
|
Th2
|
IL-5
|
− 0.08 (0.07)
|
0.283
|
− 0.11 (0.07)
|
0.008
|
− 0.20 (0.08)
|
0.009
|
− 0.14 (0.13)
|
0.267
|
Growth factors
|
FGF
|
0.08 (0.07)
|
0.231
|
0.14 (0.06)
|
0.028
|
0.15 (0.07)
|
0.050
|
0.14 (0.12)
|
0.234
|
G-CSF
|
0.11 (0.08)
|
0.187
|
0.17 (0.07)
|
0.016
|
0.15 (0.09)
|
0.082
|
0.09 (0.09)
|
0.505
|
TLR3 responses using log10 of ratio cytokines concentrations
|
Th2
|
IL-5
|
− 0.06 (0.06)
|
0.392
|
− 0. 12(0.06)
|
0.046
|
− 0.15 (0.07)
|
0.033
|
− 0.02 (0.11)
|
0.841
|
Chemokines
|
IP-10
|
0.13 (0.11)
|
0.222
|
0.22 (0.10)
|
0.026
|
0.32 (0.12)
|
0.008
|
0.10 (0.19)
|
0.584
|
Unstimulated samples using log10 of crude cytokines concentrations
|
Pro
|
IFN-α
|
− 0.11 (0.07)
|
0.154
|
− 0.14 (0.07)
|
0.038
|
− 0.15 (0.08)
|
0.069
|
− 0.01 (0.13)
|
0.948
|
IL-1RA
|
− 0.24 (0.12)
|
0.055
|
− 0.23 (0.11)
|
0.040
|
− 0.23 (0.14)
|
0.086
|
− 0.37 (0.21)
|
0.084
|
IL-1β
|
− 0.35 (0.24)
|
0.152
|
− 0.58 (0.22)
|
0.008
|
− 0.50 (0.26)
|
0.057
|
− 0.62 (0.42)
|
0.142
|
TNF
|
− 0.40 (0.26)
|
0.117
|
− 0. 61(0.23)
|
0.009
|
− 0.49 (0.28)
|
0.079
|
− 0.47 (0.45)
|
0.296
|
Anti
|
IL-10
|
− 0.22 (0.32)
|
0.485
|
− 0.60 (0.29)
|
0.041
|
− 0.45 (0.35)
|
0.204
|
− 0.92 (0.56)
|
0.105
|
IL-7
|
− 0.34 (0.10)
|
< 0.001
|
− 0.40 (0.09)
|
< 0.001
|
− 0.35 (0.11)
|
< 0.001
|
− 0.40 (0.17)
|
0.021
|
Th1
|
IL-15
|
− 0.39 (0.16)
|
0.015
|
− 0.52 (0.14)
|
< 0.001
|
− 0.52 (0.17)
|
0.003
|
− 0.36 (0.28)
|
0.190
|
IL-2
|
− 0.15 (0.08)
|
0.064
|
− 0.16 (0.07)
|
0.032
|
− 0.18 (0.09)
|
0.053
|
− 0.12 (0.14)
|
0.382
|
IFN-γ
|
− 0.14 (0.08)
|
0.094
|
− 0.17 (0.07)
|
0.023
|
− 0.21 (0.09)
|
0.024
|
− 0.10 (0.14)
|
0.494
|
Th2
|
IL-13
|
− 0.25 (0.12)
|
0.038
|
− 0.22 (0.11)
|
0.042
|
− 0.32 (0.13)
|
0.014
|
− 0.12 (0.21)
|
0.056
|
IL-4
|
− 0.27 (0.14)
|
0.057
|
− 0.40 (0.13)
|
0.002
|
− 0.26 (0.15)
|
0.096
|
− 0.07 (0.25)
|
0.769
|
Th17
|
IL-17
|
− 0.13 (0.07)
|
0.046
|
− 0.15 (0.06)
|
0.016
|
− 0.17 (0.07)
|
0.017
|
− 0.18 (0.12)
|
0.128
|
Chemokines
|
MIP-1α
|
− 0.29 (0.28)
|
0.297
|
− 0.56 (0.25)
|
0.029
|
− 0.50 (0.31)
|
0.102
|
− 0.37 (0.49)
|
0.453
|
RANTES
|
− 0.23 (0.12)
|
0.050
|
− 0.25 (0.11)
|
0.023
|
− 0.28 (0.13)
|
0.029
|
− 0.19 (0.21)
|
0.371
|
Growth factors
|
EGF
|
− 0.11 (0.07)
|
0.106
|
− 0.12 (0.06)
|
0.047
|
− 0.15 (0.07)
|
0.049
|
− 0.09 (0.12)
|
0.446
|
FGF
|
− 0.12 (0.08)
|
0.151
|
− 0.15 (0.08)
|
0.049
|
− 0. 17(0.09)
|
0.070
|
− 0.17 (0.15)
|
0.244
|
G-CSF
|
− 0.21 (0.17)
|
0.229
|
− 0.37 (0.15)
|
0.019
|
− 0.37 (0.15)
|
0.045
|
− 0.33 (0.30)
|
0.276
|
GM-CSF
|
− 0.36 (0.19)
|
0.058
|
− 0.59 (0.17)
|
< 0.001
|
− 0.60 (0.21)
|
0.004
|
− 0.59 (0.33)
|
0.079
|
HGF
|
− 0.19 (0.07)
|
0.008
|
− 0.20 (0.06)
|
0.002
|
− 0.19 (0.08)
|
0.015
|
− 0.15 (0.12)
|
0.221
|
VEGF
|
− 0.45 (0.22)
|
0.041
|
− 0.59 (0.20)
|
0.003
|
− 0.43 (0.24)
|
0.070
|
− 0.35 (0.38)
|
0.356
|
- PM placental malaria, Coeff coefficient, SE standard error, Pro proinflammatory cytokines, P p value, Anti anti-inflammatory cytokines, Th1 Th1-type cytokines, Th2 Th2-type cytokines, Th17 Th17, type cytokines. *Only cytokines whose concentrations are significantly modified by categories of PME are presented. Non-exposed category was used as reference in each model. Significant results are shown in italic